Enhanced MET translation and signaling sustains K-Ras driven proliferation under anchorage-independent growth conditions

作者: Saori Fujita-Sato , Jacqueline Galeas , Morgan Truitt , Cameron Pitt , Anatoly Urisman

DOI: 10.1158/0008-5472.CAN-14-1623

关键词:

摘要: Oncogenic K-Ras mutation occurs frequently in several types of cancers, including pancreatic and lung cancers. Tumors with are resistant to chemotherapeutic drugs as well molecular targeting agents. Although numerous approaches ongoing find effective ways treat these tumors, there still no therapies for mutant cancer patients. Here we report that cancers more dependent on anchorage-independent culture conditions than monolayer conditions. In seeking determine mechanisms contribute the dependency conditions, discovered involvement Met K-Ras–dependent, cell growth. The signaling pathway is enhanced plays an indispensable role growth even cells which not amplified. Indeed, expression elevated under regulated by a MAPK/ERK kinase (MEK)-dependent manner. Remarkably, spite global downregulation mRNA translation during growth, specifically Importantly, ectopic active rescues ablation-derived suppression, indicating K-Ras–mediated drives “K-Ras addiction” Our results indicate essential suggests pharmacological inhibitors could be tumor Cancer Res; 75(14); 2851–62. ©2015 AACR .

参考文章(42)
Muschel Rj, Bakanauskas Vj, Stanbridge Ej, Bernhard Ej, Cerniglia Gj, McKenna Wg, Gupta Ak, Gupta S, Soto D, Direct Evidence for the Contribution of Activated N-ras and K-ras Oncogenes to Increased Intrinsic Radiation Resistance in Human Tumor Cell Lines Cancer Research. ,vol. 60, pp. 6597- 6600 ,(2000)
Paraic A. Kenny, Genee Y. Lee, Connie A. Myers, Richard M. Neve, Jeremy R. Semeiks, Paul T. Spellman, Katrin Lorenz, Eva H. Lee, Mary Helen Barcellos-Hoff, Ole W. Petersen, Joe W. Gray, Mina J. Bissell, The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression Molecular Oncology. ,vol. 1, pp. 84- 96 ,(2007) , 10.1016/J.MOLONC.2007.02.004
Yuliya Pylayeva-Gupta, Elda Grabocka, Dafna Bar-Sagi, RAS oncogenes: weaving a tumorigenic web Nature Reviews Cancer. ,vol. 11, pp. 761- 774 ,(2011) , 10.1038/NRC3106
Solange Peters, Alex A. Adjei, MET: a promising anticancer therapeutic target Nature Reviews Clinical Oncology. ,vol. 9, pp. 314- 326 ,(2012) , 10.1038/NRCLINONC.2012.71
Yikun Li, Songqing Fan, Junghui Koo, Ping Yue, Zhuo (Georgia) Chen, Taofeek K. Owonikoko, Suresh S. Ramalingam, Fadlo R. Khuri, Shi-Yong Sun, Elevated expression of eukaryotic translation initiation factor 4E is associated with proliferation, invasion and acquired resistance to erlotinib in lung cancer. Cancer Biology & Therapy. ,vol. 13, pp. 272- 280 ,(2012) , 10.4161/CBT.18923
Deborah Silvera, Rezina Arju, Farbod Darvishian, Paul H. Levine, Ladan Zolfaghari, Judith Goldberg, Tsivia Hochman, Silvia C. Formenti, Robert J. Schneider, Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer Nature Cell Biology. ,vol. 11, pp. 903- 908 ,(2009) , 10.1038/NCB1900
Daquan Meng, Mingli Yuan, Xiaojuan Li, Lijun Chen, Jie Yang, Xin Zhao, Wanli Ma, Jianbao Xin, Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis. Lung Cancer. ,vol. 81, pp. 1- 10 ,(2013) , 10.1016/J.LUNGCAN.2013.03.019
Ryohei Katayama, Aki Aoyama, Takao Yamori, Jie Qi, Tomoko Oh-hara, Youngchul Song, Jeffrey A. Engelman, Naoya Fujita, Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition Cancer Research. ,vol. 73, pp. 3087- 3096 ,(2013) , 10.1158/0008-5472.CAN-12-3256
C Mascaux, N Iannino, B Martin, M Paesmans, T Berghmans, M Dusart, A Haller, P Lothaire, A-P Meert, S Noel, J-J Lafitte, J-P Sculier, The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis British Journal of Cancer. ,vol. 92, pp. 131- 139 ,(2005) , 10.1038/SJ.BJC.6602258
Timothy R. Wilson, Jane Fridlyand, Yibing Yan, Elicia Penuel, Luciana Burton, Emily Chan, Jing Peng, Eva Lin, Yulei Wang, Jeff Sosman, Antoni Ribas, Jiang Li, John Moffat, Daniel P. Sutherlin, Hartmut Koeppen, Mark Merchant, Richard Neve, Jeff Settleman, Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors Nature. ,vol. 487, pp. 505- 509 ,(2012) , 10.1038/NATURE11249